| Product NDC: | 16590-885 |
| Proprietary Name: | KADIAN |
| Non Proprietary Name: | MORPHINE SULFATE |
| Active Ingredient(s): | 200 mg/1 & nbsp; MORPHINE SULFATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16590-885 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020616 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090407 |
| Package NDC: | 16590-885-60 |
| Package Description: | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-885-60) |
| NDC Code | 16590-885-60 |
| Proprietary Name | KADIAN |
| Package Description | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16590-885-60) |
| Product NDC | 16590-885 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | MORPHINE SULFATE |
| Dosage Form Name | CAPSULE, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20090407 |
| Marketing Category Name | NDA |
| Labeler Name | STAT RX USA LLC |
| Substance Name | MORPHINE SULFATE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |